Phase I Clinical Trial Unit for Therapeutics
$97,254N01FY2012AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.
View original record on NIH RePORTER →